Back to Browse Journals » Clinical Pharmacology: Advances and Applications » Volume 2

Nanoparticle-labeled stem cells: a novel therapeutic vehicle

Authors Abir O El-Sadik, Afaf El-Ansary, Sherif M Sabry

Published Date March 2010 Volume 2010:2 Pages 9—16

DOI http://dx.doi.org/10.2147/CPAA.S8931

Published 16 March 2010

Abir O El-Sadik1, Afaf El-Ansary2, Sherif M Sabry3

1Stem Cell Unit, Anatomy Department, College of Medicine, Health Science Colleges; 2Biochemistry Department, Science College, King Saud University; 3Anatomy Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Abstract: Nanotechnology has been described as a general purpose technology. It has already generated a range of inventions and innovations. Development of nanotechnology will provide clinical medicine with a range of new diagnostic and therapeutic opportunities such as medical imaging, medical diagnosis, drug delivery, and cancer detection and management. Nanoparticles such as manganese, polystyrene, silica, titanium oxide, gold, silver, carbon, quantum dots, and iron oxide have received enormous attention in the creation of new types of analytical tools for biotechnology and life sciences. Labeling of stem cells with nanoparticles overcame the problems in homing and fixing stem cells to their desired site and guiding extension of stem cells to specific directions. Although the biologic effects of some nanoparticles have already been assessed, information on toxicity and possible mechanisms of various particle types remains inadequate. The aim of this review is to give an overview of the mechanisms of internalization and distribution of nanoparticles inside stem cells, as well as the influence of different types of nanoparticles on stem cell viability, proliferation, differentiation, and cytotoxicity, and to assess the role of nanoparticles in tracking the fate of stem cells used in tissue regeneration.
Keywords: nanoparticles, stem cells, uptake, differentiation, cytotoxicity, tracking

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Potential sources of stem cells as a regenerative therapy for Parkinson's disease

Abir Oueida El-Sadik

Stem Cells and Cloning: Advances and Applications 2010, 3:183-191

Published Date: 6 December 2010

Readers of this article also read: